• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW

ACTINOGEN MEDICAL LIMITED - Announcements

3.57% ! 2.7¢
Market Cap $85.73M  !

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Recently Updated

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight arrow Created with Sketch.

Actinogen reaches 100th participant milestone

Announcements



ACW Lapse of Unlisted Options03/01/17 download Created with Sketch. 97.74KB
ACW Trading HaltPRICE SENSITIVE30/12/16 download Created with Sketch. 202.78KB
ACW Significant Advance in Development of Alzheimer's DrugPRICE SENSITIVE19/12/16 download Created with Sketch. 157.04KB
ACW Xanamem Research Presented at CTAD06/12/16 download Created with Sketch. 131.74KB
ACW Appendix 3Z30/11/16 download Created with Sketch. 166.86KB
ACW Resignation of Director30/11/16 download Created with Sketch. 103.58KB
ACW Results of Annual General Meeting30/11/16 download Created with Sketch. 198.16KB
ACW CEO's Presentation to AGM30/11/16 download Created with Sketch. 1.72MB
ACW Chairman's AGM Address30/11/16 download Created with Sketch. 139.65KB
ACW Appendix 4C - quarterly-ACW.AX PRICE SENSITIVE26/10/16 download Created with Sketch. 48.32KB
ACW Annual Report to Shareholders-ACW.AX 24/10/16 download Created with Sketch. 2.24MB
ACW Notice of Annual General Meeting/Proxy Form-ACW.AX 24/10/16 download Created with Sketch. 445.52KB
ACW Ceasing to be a substantial holder-ACW.AX 14/10/16 download Created with Sketch. 1.17MB
ACW Ceasing to be a substantial holder-ACW.AX 06/10/16 download Created with Sketch. 360.86KB
ACW Changes to the Actinogen Medical Board-ACW.AX 05/10/16 download Created with Sketch. 106.89KB
ACW FDA Feedback on Xanamem Alzheimer's Trail-ACW.AX PRICE SENSITIVE29/09/16 download Created with Sketch. 105.12KB
ACW R&D Tax Rebate-ACW.AX PRICE SENSITIVE05/09/16 download Created with Sketch. 104.59KB
ACW Investor Update-August 2016-ACW.AX 01/09/16 download Created with Sketch. 800.16KB
ACW Appendix 4E & Financial Statements-ACW.AX PRICE SENSITIVE31/08/16 download Created with Sketch. 2.55MB
ACW Appendix 4G-ACW.AX 31/08/16 download Created with Sketch. 87.72KB
ACW Ceasing to be a substantial holder-ACW.AX 24/08/16 download Created with Sketch. 1012.35KB
ACW Less Than Marketable Parcel Sale-ACW.AX 17/08/16 download Created with Sketch. 225.19KB
ACW Landmark Research on Excess Cortisol & Alzheimer's Disease-ACW.AX PRICE SENSITIVE28/07/16 download Created with Sketch. 202.76KB
ACW US Patent Granted-Further Extends Xanamem Protection-ACW.AX PRICE SENSITIVE20/07/16 download Created with Sketch. 120.15KB
ACW US Roadshow Investor Presentation-ACW.AX 15/07/16 download Created with Sketch. 2.62MB
ACW Appendix 4C - quarterly-ACW.AX PRICE SENSITIVE15/07/16 download Created with Sketch. 83.2KB
ACW Issue of Employee Options-ACW.AX 08/07/16 download Created with Sketch. 244.37KB
ACW Xanamem & AIBL to showcase Cortisol Hypothesis in Alzheimers-ACW.AX 29/06/16 download Created with Sketch. 147.21KB
ACW US FDA Feedback Enhances Alzheimers Study-ACW.AX PRICE SENSITIVE08/06/16 download Created with Sketch. 111.02KB
ACW Change of Share Register Notification-ACW.AX 20/05/16 download Created with Sketch. 96.99KB
ACW Section 708A Notice-ACW.AX 06/05/16 download Created with Sketch. 88KB
ACW Appendix 3B-ACW.AX 06/05/16 download Created with Sketch. 146.29KB
ACW BioEquity & Ausbiotech Asia Investor Presentation May 2016-ACW.AX 03/05/16 download Created with Sketch. 3.39MB
ACW Appendix 4C - quarterly-ACW.AX PRICE SENSITIVE15/04/16 download Created with Sketch. 83.08KB
ACW Launch of XanADu Phase II Clinical TrialPRICE SENSITIVE22/03/16 download Created with Sketch. 140.86KB
ACW Xanamem Cortisol Hypothesis-Investor Presentation10/03/16 download Created with Sketch. 2.06MB
ACW Appendix 4D & Half Year ReportPRICE SENSITIVE19/02/16 download Created with Sketch. 611.69KB
ACW R&D RebatePRICE SENSITIVE09/02/16 download Created with Sketch. 95.27KB
ACW Appendix 4C - quarterlyPRICE SENSITIVE27/01/16 download Created with Sketch. 83KB
ACW Appendix 3Y-Dr Bill Ketelbey04/01/16 download Created with Sketch. 23.98KB
ACW Investor Update-December 201501/12/15 download Created with Sketch. 1.92MB
ACW Change of Company Name17/11/15 download Created with Sketch. 94.24KB
ACW Results of AGM12/11/15 download Created with Sketch. 89.8KB
ACW CEO's AGM Presentation12/11/15 download Created with Sketch. 1.16MB
ACW Chairman's AGM Address12/11/15 download Created with Sketch. 132.76KB
ACW Release of Securities from Voluntary Escrow06/11/15 download Created with Sketch. 71.57KB
ACW Appendix 4C - quarterlyPRICE SENSITIVE15/10/15 download Created with Sketch. 82.27KB
ACW Annual Report to shareholders07/10/15 download Created with Sketch. 1011.93KB
ACW Notice of Annual General Meeting/Proxy Form07/10/15 download Created with Sketch. 591.18KB
ACW Understanding Alzheimer's Symposium07/10/15 download Created with Sketch. 129.78KB
ACW Expiry of Listed Options30/09/15 download Created with Sketch. 74.19KB
ACW Positive Trial Results for Alzheimers Drug XanamemPRICE SENSITIVE29/09/15 download Created with Sketch. 153.84KB
ACW Trading HaltPRICE SENSITIVE28/09/15 download Created with Sketch. 367.84KB
ACW Expiry of Listed Options & Waiver of LIsting Rule 6.2431/08/15 download Created with Sketch. 115.15KB
ACW Appendix 4G31/08/15 download Created with Sketch. 96.87KB
ACW Appendix 4E & Financial StatementsPRICE SENSITIVE31/08/15 download Created with Sketch. 1.12MB
ACW Investor Update-August 201517/08/15 download Created with Sketch. 1.02MB
ACW Employee Share Plan Vesting Conditions Met12/08/15 download Created with Sketch. 86.62KB
ACW Employee Share Plan Vesting Conditions Met11/08/15 download Created with Sketch. 86.23KB
ACW Clinical Trial Successfully Completed with XanamemPRICE SENSITIVE11/08/15 download Created with Sketch. 112.92KB
ACW Appendix 4C - quarterlyPRICE SENSITIVE16/07/15 download Created with Sketch. 83.95KB
ACW Investor Roadshow07/07/15 download Created with Sketch. 900.84KB
ACW Change of Address & Executive Chairman Agreement26/06/15 download Created with Sketch. 100.27KB
ACW Excellent Research Progress with Promising Alzheimers DrugPRICE SENSITIVE11/06/15 download Created with Sketch. 106.42KB
ACW Employee Share Plan Vesting Conditions Met21/05/15 download Created with Sketch. 90.08KB
ACW ASX Spotlight Series Singapore/Hong Kong May 201521/05/15 download Created with Sketch. 981.06KB
ACW Appendix 3Y-Dr Anton Uvarov20/05/15 download Created with Sketch. 23.11KB
ACW Appendix 3Y-Dr Jason Loveridge20/05/15 download Created with Sketch. 24.38KB
ACW Appendix 3Y-Dr Bill Ketelbey20/05/15 download Created with Sketch. 23.18KB
ACW Appendix 3Y-Mr Martin Rogers20/05/15 download Created with Sketch. 24.76KB
ACW Appendix 3B20/05/15 download Created with Sketch. 141.96KB
ACW Notice of Change of Interests of Substantial Holder14/05/15 download Created with Sketch. 373.21KB
ACW Successful Completion of 1st Stage of Alzheimer's Drug TrialPRICE SENSITIVE12/05/15 download Created with Sketch. 106.59KB
ACW Change in substantial holding07/05/15 download Created with Sketch. 39.29KB
ACW Ceasing to be a substantial holder07/05/15 download Created with Sketch. 557.96KB
ACW Information Required Under Listing Rule 3.10.5A06/05/15 download Created with Sketch. 89.12KB
ACW Section 708A Notice06/05/15 download Created with Sketch. 85.18KB
ACW Appendix 3B06/05/15 download Created with Sketch. 142.82KB
ACW Notice under ASIC Class Order (CO 09/425)01/05/15 download Created with Sketch. 86.3KB
ACW Share Purchase PlanPRICE SENSITIVE30/04/15 download Created with Sketch. 454.15KB
ACW Change in Substantial Shareholding28/04/15 download Created with Sketch. 22.91KB
ACW Change in Substantial Shareholding x 227/04/15 download Created with Sketch. 4.37MB
ACW Ethics Approval Granted for 2nd Stage of Phase 1 StudyPRICE SENSITIVE24/04/15 download Created with Sketch. 105.67KB
ACW Appendix 4CPRICE SENSITIVE24/04/15 download Created with Sketch. 85.6KB
ACW Successful Capital Raising to Support Alzheimers ResearchPRICE SENSITIVE24/04/15 download Created with Sketch. 128.73KB
ACW Trading HaltPRICE SENSITIVE22/04/15 download Created with Sketch. 201.58KB
ACW Further Clinical Trial Update on XanamemPRICE SENSITIVE16/04/15 download Created with Sketch. 106.28KB
ACW Xanamem Clinical Advisory Board Conference Call Transcript16/04/15 download Created with Sketch. 105.84KB
ACW Investor Update-April 201515/04/15 download Created with Sketch. 1.83MB
ACW Xanamem Clinical Advisory Board Conference Call13/04/15 download Created with Sketch. 137.08KB
ACW EU Patent Granted-Further Extends Xanamem ProtectionPRICE SENSITIVE13/04/15 download Created with Sketch. 160.75KB
ACW ACW Investor Presentation-April 201513/04/15 download Created with Sketch. 893.49KB
ACW Clinical Trial Update-Xanamem Drug for Alzheimers DementiaPRICE SENSITIVE24/03/15 download Created with Sketch. 104.7KB
ACW Powerhouse Alzheimer's Experts to Drive Xanamem Development17/03/15 download Created with Sketch. 116.25KB
ACW Response to Price Query LetterPRICE SENSITIVE12/03/15 download Created with Sketch. 138.12KB
ACW Investor Presentation-March 201509/03/15 download Created with Sketch. 799.55KB
ACW Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE27/02/15 download Created with Sketch. 898.76KB
ACW Employee Share Plan Vesting Conditions Met24/02/15 download Created with Sketch. 87.52KB
ACW First Participants Recruited for 2nd Phase 1 Xanamem StudyPRICE SENSITIVE24/02/15 download Created with Sketch. 107.66KB
ACW Investor Presentation-February 201517/02/15 download Created with Sketch. 1.06MB
ACW Lapse of Unlisted Options
03/01/17 download Created with Sketch. 97.74KB
ACW Trading Halt
30/12/16PRICE SENSITIVE download Created with Sketch. 202.78KB
ACW Significant Advance in Development of Alzheimer's Drug
19/12/16PRICE SENSITIVE download Created with Sketch. 157.04KB
ACW Xanamem Research Presented at CTAD
06/12/16 download Created with Sketch. 131.74KB
ACW Appendix 3Z
30/11/16 download Created with Sketch. 166.86KB
ACW Resignation of Director
30/11/16 download Created with Sketch. 103.58KB
ACW Results of Annual General Meeting
30/11/16 download Created with Sketch. 198.16KB
ACW CEO's Presentation to AGM
30/11/16 download Created with Sketch. 1.72MB
ACW Chairman's AGM Address
30/11/16 download Created with Sketch. 139.65KB
ACW Appendix 4C - quarterly-ACW.AX
26/10/16PRICE SENSITIVE download Created with Sketch. 48.32KB
ACW Annual Report to Shareholders-ACW.AX
24/10/16 download Created with Sketch. 2.24MB
ACW Notice of Annual General Meeting/Proxy Form-ACW.AX
24/10/16 download Created with Sketch. 445.52KB
ACW Ceasing to be a substantial holder-ACW.AX
14/10/16 download Created with Sketch. 1.17MB
ACW Ceasing to be a substantial holder-ACW.AX
06/10/16 download Created with Sketch. 360.86KB
ACW Changes to the Actinogen Medical Board-ACW.AX
05/10/16 download Created with Sketch. 106.89KB
ACW FDA Feedback on Xanamem Alzheimer's Trail-ACW.AX
29/09/16PRICE SENSITIVE download Created with Sketch. 105.12KB
ACW R&D Tax Rebate-ACW.AX
05/09/16PRICE SENSITIVE download Created with Sketch. 104.59KB
ACW Investor Update-August 2016-ACW.AX
01/09/16 download Created with Sketch. 800.16KB
ACW Appendix 4E & Financial Statements-ACW.AX
31/08/16PRICE SENSITIVE download Created with Sketch. 2.55MB
ACW Appendix 4G-ACW.AX
31/08/16 download Created with Sketch. 87.72KB
ACW Ceasing to be a substantial holder-ACW.AX
24/08/16 download Created with Sketch. 1012.35KB
ACW Less Than Marketable Parcel Sale-ACW.AX
17/08/16 download Created with Sketch. 225.19KB
ACW Landmark Research on Excess Cortisol & Alzheimer's Disease-ACW.AX
28/07/16PRICE SENSITIVE download Created with Sketch. 202.76KB
ACW US Patent Granted-Further Extends Xanamem Protection-ACW.AX
20/07/16PRICE SENSITIVE download Created with Sketch. 120.15KB
ACW US Roadshow Investor Presentation-ACW.AX
15/07/16 download Created with Sketch. 2.62MB
ACW Appendix 4C - quarterly-ACW.AX
15/07/16PRICE SENSITIVE download Created with Sketch. 83.2KB
ACW Issue of Employee Options-ACW.AX
08/07/16 download Created with Sketch. 244.37KB
ACW Xanamem & AIBL to showcase Cortisol Hypothesis in Alzheimers-ACW.AX
29/06/16 download Created with Sketch. 147.21KB
ACW US FDA Feedback Enhances Alzheimers Study-ACW.AX
08/06/16PRICE SENSITIVE download Created with Sketch. 111.02KB
ACW Change of Share Register Notification-ACW.AX
20/05/16 download Created with Sketch. 96.99KB
ACW Section 708A Notice-ACW.AX
06/05/16 download Created with Sketch. 88KB
ACW Appendix 3B-ACW.AX
06/05/16 download Created with Sketch. 146.29KB
ACW BioEquity & Ausbiotech Asia Investor Presentation May 2016-ACW.AX
03/05/16 download Created with Sketch. 3.39MB
ACW Appendix 4C - quarterly-ACW.AX
15/04/16PRICE SENSITIVE download Created with Sketch. 83.08KB
ACW Launch of XanADu Phase II Clinical Trial
22/03/16PRICE SENSITIVE download Created with Sketch. 140.86KB
ACW Xanamem Cortisol Hypothesis-Investor Presentation
10/03/16 download Created with Sketch. 2.06MB
ACW Appendix 4D & Half Year Report
19/02/16PRICE SENSITIVE download Created with Sketch. 611.69KB
ACW R&D Rebate
09/02/16PRICE SENSITIVE download Created with Sketch. 95.27KB
ACW Appendix 4C - quarterly
27/01/16PRICE SENSITIVE download Created with Sketch. 83KB
ACW Appendix 3Y-Dr Bill Ketelbey
04/01/16 download Created with Sketch. 23.98KB
ACW Investor Update-December 2015
01/12/15 download Created with Sketch. 1.92MB
ACW Change of Company Name
17/11/15 download Created with Sketch. 94.24KB
ACW Results of AGM
12/11/15 download Created with Sketch. 89.8KB
ACW CEO's AGM Presentation
12/11/15 download Created with Sketch. 1.16MB
ACW Chairman's AGM Address
12/11/15 download Created with Sketch. 132.76KB
ACW Release of Securities from Voluntary Escrow
06/11/15 download Created with Sketch. 71.57KB
ACW Appendix 4C - quarterly
15/10/15PRICE SENSITIVE download Created with Sketch. 82.27KB
ACW Annual Report to shareholders
07/10/15 download Created with Sketch. 1011.93KB
ACW Notice of Annual General Meeting/Proxy Form
07/10/15 download Created with Sketch. 591.18KB
ACW Understanding Alzheimer's Symposium
07/10/15 download Created with Sketch. 129.78KB
ACW Expiry of Listed Options
30/09/15 download Created with Sketch. 74.19KB
ACW Positive Trial Results for Alzheimers Drug Xanamem
29/09/15PRICE SENSITIVE download Created with Sketch. 153.84KB
ACW Trading Halt
28/09/15PRICE SENSITIVE download Created with Sketch. 367.84KB
ACW Expiry of Listed Options & Waiver of LIsting Rule 6.24
31/08/15 download Created with Sketch. 115.15KB
ACW Appendix 4G
31/08/15 download Created with Sketch. 96.87KB
ACW Appendix 4E & Financial Statements
31/08/15PRICE SENSITIVE download Created with Sketch. 1.12MB
ACW Investor Update-August 2015
17/08/15 download Created with Sketch. 1.02MB
ACW Employee Share Plan Vesting Conditions Met
12/08/15 download Created with Sketch. 86.62KB
ACW Employee Share Plan Vesting Conditions Met
11/08/15 download Created with Sketch. 86.23KB
ACW Clinical Trial Successfully Completed with Xanamem
11/08/15PRICE SENSITIVE download Created with Sketch. 112.92KB
ACW Appendix 4C - quarterly
16/07/15PRICE SENSITIVE download Created with Sketch. 83.95KB
ACW Investor Roadshow
07/07/15 download Created with Sketch. 900.84KB
ACW Change of Address & Executive Chairman Agreement
26/06/15 download Created with Sketch. 100.27KB
ACW Excellent Research Progress with Promising Alzheimers Drug
11/06/15PRICE SENSITIVE download Created with Sketch. 106.42KB
ACW Employee Share Plan Vesting Conditions Met
21/05/15 download Created with Sketch. 90.08KB
ACW ASX Spotlight Series Singapore/Hong Kong May 2015
21/05/15 download Created with Sketch. 981.06KB
ACW Appendix 3Y-Dr Anton Uvarov
20/05/15 download Created with Sketch. 23.11KB
ACW Appendix 3Y-Dr Jason Loveridge
20/05/15 download Created with Sketch. 24.38KB
ACW Appendix 3Y-Dr Bill Ketelbey
20/05/15 download Created with Sketch. 23.18KB
ACW Appendix 3Y-Mr Martin Rogers
20/05/15 download Created with Sketch. 24.76KB
ACW Appendix 3B
20/05/15 download Created with Sketch. 141.96KB
ACW Notice of Change of Interests of Substantial Holder
14/05/15 download Created with Sketch. 373.21KB
ACW Successful Completion of 1st Stage of Alzheimer's Drug Trial
12/05/15PRICE SENSITIVE download Created with Sketch. 106.59KB
ACW Change in substantial holding
07/05/15 download Created with Sketch. 39.29KB
ACW Ceasing to be a substantial holder
07/05/15 download Created with Sketch. 557.96KB
ACW Information Required Under Listing Rule 3.10.5A
06/05/15 download Created with Sketch. 89.12KB
ACW Section 708A Notice
06/05/15 download Created with Sketch. 85.18KB
ACW Appendix 3B
06/05/15 download Created with Sketch. 142.82KB
ACW Notice under ASIC Class Order (CO 09/425)
01/05/15 download Created with Sketch. 86.3KB
ACW Share Purchase Plan
30/04/15PRICE SENSITIVE download Created with Sketch. 454.15KB
ACW Change in Substantial Shareholding
28/04/15 download Created with Sketch. 22.91KB
ACW Change in Substantial Shareholding x 2
27/04/15 download Created with Sketch. 4.37MB
ACW Ethics Approval Granted for 2nd Stage of Phase 1 Study
24/04/15PRICE SENSITIVE download Created with Sketch. 105.67KB
ACW Appendix 4C
24/04/15PRICE SENSITIVE download Created with Sketch. 85.6KB
ACW Successful Capital Raising to Support Alzheimers Research
24/04/15PRICE SENSITIVE download Created with Sketch. 128.73KB
ACW Trading Halt
22/04/15PRICE SENSITIVE download Created with Sketch. 201.58KB
ACW Further Clinical Trial Update on Xanamem
16/04/15PRICE SENSITIVE download Created with Sketch. 106.28KB
ACW Xanamem Clinical Advisory Board Conference Call Transcript
16/04/15 download Created with Sketch. 105.84KB
ACW Investor Update-April 2015
15/04/15 download Created with Sketch. 1.83MB
ACW Xanamem Clinical Advisory Board Conference Call
13/04/15 download Created with Sketch. 137.08KB
ACW EU Patent Granted-Further Extends Xanamem Protection
13/04/15PRICE SENSITIVE download Created with Sketch. 160.75KB
ACW ACW Investor Presentation-April 2015
13/04/15 download Created with Sketch. 893.49KB
ACW Clinical Trial Update-Xanamem Drug for Alzheimers Dementia
24/03/15PRICE SENSITIVE download Created with Sketch. 104.7KB
ACW Powerhouse Alzheimer's Experts to Drive Xanamem Development
17/03/15 download Created with Sketch. 116.25KB
ACW Response to Price Query Letter
12/03/15PRICE SENSITIVE download Created with Sketch. 138.12KB
ACW Investor Presentation-March 2015
09/03/15 download Created with Sketch. 799.55KB
ACW Appendix 4D & Half-Year Financial Statements
27/02/15PRICE SENSITIVE download Created with Sketch. 898.76KB
ACW Employee Share Plan Vesting Conditions Met
24/02/15 download Created with Sketch. 87.52KB
ACW First Participants Recruited for 2nd Phase 1 Xanamem Study
24/02/15PRICE SENSITIVE download Created with Sketch. 107.66KB
ACW Investor Presentation-February 2015
17/02/15 download Created with Sketch. 1.06MB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $85.73M
Open High Low Value Volume
2.7¢ 2.8¢ 2.6¢ $99.67K 3.727M

Buyers (Bids)

No. Vol. Price($)
4 2388449 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 625000 3
View Market Depth
Last trade - 16.10pm 10/09/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.